Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. apr. Bart De Spiegeleer

Faculty of Pharmaceutical Sciences > Department of Pharmaceutical analysis

Work address: Ottergemsesteenweg 460
9000 Gent
Email: Bart.DeSpiegeleer@UGent.be
ORCID iD: 0000-0001-6794-3108

Show Sort by

Add to list
- Journal Article
- open access
A bioanalytical screening method for Enterococcus faecalis RNPP-type quorum sensing peptides in murine feces

Frederick Verbeke (UGent) , Nathan Debunne (UGent) , Yorick Janssens (UGent) , Bart De Spiegeleer (UGent) and Evelien Wynendaele (UGent)

(2022) Bioanalysis.
Add to list
- Journal Article
- open access
Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1

Aaron G. Poth, Francis C.K. Chiu, Sofie Stalmans (UGent) , Brett R. Hamilton, Yen-Hua Huang, David M. Shackleford, Rahul Patil, Thao T. Le, Meng-Wei Kan, Thomas Durek, et al.

(2021) Medicine in Drug Discovery.
Add to list
BBPpred : sequence-based prediction of blood-brain barrier peptides with feature representation learning and logistic regression

Ruyu Dai, Wei Zhang, Wending Tang, Evelien Wynendaele (UGent) , Qizhi Zhu, Yannan Bin, Bart De Spiegeleer (UGent) and Junfeng Xia

(2021) JOURNAL OF CHEMICAL INFORMATION AND MODELING. 61(1). p.525-534
Add to list
- Journal Article
- A1
- open access
Conformational stability as a quality attribute for the cell therapy raw material human serum albumin

Evelien Wynendaele (UGent) , Gamaliel Junren Ma, Xiaolong Xu, Nam-Joon Cho and Bart De Spiegeleer (UGent)

(2021) RSC ADVANCES. 11(25). p.15332-15339
Add to list
- Journal Article
- A1
- open access
Apoptosis imaging in oncology by means of positron emission tomography : a review

Christophe Van De Wiele (UGent) , Sezgin Ustmert, Bart De Spiegeleer (UGent) , Pieter-Jan De Jonghe, Mike Sathekge and Maes Alex

(2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(5).
Add to list
- Miscellaneous
- open access
Adjunctive use of statins for COVID-19

Mike Sathekge, Geert Byttebier, Bart De Spiegeleer (UGent) , Bo Saxberg, Veronica Ueckermann, Luc Belmans, Myriam Alexander and David Fedson

(2021) JOURNAL OF CLINICAL MEDICINE. 10(7).
Add to list
Faecal microbiota transplants : why do we not consider them as Advanced Therapy Medicinal Products?

Frederick Verbeke (UGent) and Bart De Spiegeleer (UGent)

(2021) UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 9(4). p.519-520
Add to list
Sustainability in drug discovery

Evelien Wynendaele (UGent) , Christophe Furman, Bartosz Wielgomas, Per Larsson, Eelko Hak, Thomas Block (UGent) , Serge Van Calenbergh (UGent) , Nicolas Willand, Michal Markuszewski, Luke R. Odell, et al.

(2021) MEDICINE IN DRUG DISCOVERY.
Add to list
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs

Geert Byttebier, Luc Belmans (UGent) , Myriam Alexander, Bo E. H. Saxberg, Bart De Spiegeleer (UGent) , Anton De Spiegeleer (UGent) , Nick Devreker, Jens Van Praet (UGent) , Karolien Vanhove, Reinhilde Reybrouck, et al.

(2021) HUMAN VACCINES & IMMUNOTHERAPEUTICS. 17(9). p.2841-2850
Add to list
- Journal Article
- A1
- open access
PapRIV : a BV-2 microglial cell activating quorum sensing peptide

Yorick Janssens (UGent) , Nathan Debunne (UGent) , Anton De Spiegeleer (UGent) , Evelien Wynendaele (UGent) , Marta Planas, Lidia Feliu, Alessandra Quarta, Christel Claes, Debby Van Dam, Peter Paul De Deyn, et al.

(2021) SCIENTIFIC REPORTS. 11(1).

1
2
3
4
…
38
39

Next →